The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Evaluation of venous thromboembolism (VTE) risk among ambulatory patients with pancreatic cancer in a real-world setting.
Jay Lin
Consultant or Advisory Role - Sanofi
Stock Ownership - Sanofi
Research Funding - Sanofi
Mehul R. Dalal
Employment or Leadership Position - Sanofi
Gregory Clayton Connolly
No relevant relationships to disclose
Alok A. Khorana
Consultant or Advisory Role - Roche/Genentech; Sanofi
Honoraria - Boehringer Ingelheim; Eisai; Ortho Biotech; Roche/Genentech; Sanofi
Research Funding - Eisai; LEO Pharma; Ortho Biotech; Sanofi